Deutsche Bank Downgrades AstraZeneca (AZN) to Hold

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. WDC
3. DECK
4. BYD
5. WCN
6. SPOT
7. FIX
8. TSCO
9. BE
10. SLM

Go back to Deutsche Bank Downgrades AstraZeneca (AZN) to Hold

AstraZeneca Full year and Q4 2023 Financial Results

February 8, 2024 2:04 AM EST

Strong growth and pipeline momentum with three new medicines approved since the third quarter

CAMBRIDGE, United Kingdom--(BUSINESS WIRE)-- AstraZeneca:

Revenue and EPS summary

 

 

FY 2023

Q4 2023

 

 

 

%... More

SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain

February 7, 2024 6:51 AM EST

SOPHiA GENETICS and AstraZeneca Spain expand HRD testing program to support molecular diagnosis of ovarian cancer in Spain

BOSTON and ROLLE, Switzerland and MADRID, Feb. 7, 2024 /PRNewswire/ -- SOPHiA... More

AstraZeneca expands US manufacturing footprint to accelerate ambitions in next-generation cell therapy discovery and development

February 6, 2024 9:00 AM EST

New facility in Rockville, Maryland will focus on manufacturing for critical cancer trials and launch of its commercial cell therapy platforms

WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell therapy platforms in the US for critical cancer trials and future commercial supply. More than 150 new highly skilled jobs will be created to initially focus on manufacturing T-cell therapies to enable clinical trials to be conducted around the world. Over time, the site may expand its focus to support other disease... More